Skip to main content
Log in

Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

The objective of this study was to compare the two most frequently used asthma-specific quality of life (QOL) questionnaires and two generic QOL questionnaires with clinical data in order to establish their ability to discriminate in asthma severity, also referred to as cross-sectional construct validity. We conducted a multicentre, randomized, placebo-controlled study investigating the long-term effects of the long-acting ß2-agonist formoterol in asthma patients using inhaled corticosteroids and short-acting ß2-agonists. Before randomization, the peak expiratory flow (PEF) and use of ß2-agonists for relief of symptoms were recorded twice daily for 1 month. At the end of the run-in period, the forced expiratory volume in 1s (FEV1), airway hyper-responsiveness (PC20 methacholine) and QOL were measured, using two asthma-specific questionnaires, the Asthma Quality of Life Questionnaire (AQLQ) and the Living with Asthma Quality of Life Questionnaire (LWAQ), as well as two generic questionnaires, the Short Form 36 (SF-36) and the Psychological General Well Being (PGWB) index. The quality of life of the patients (n=110) was only mildly impaired. The mean symptom score was 3.6 on a scale of 0-21 and the mean FEV1 was 65% of that predicted. The correlations between the QOL parameters and objective measures of asthma severity, such as the FEV1, PEF and PC20, were low (0.01-0.37). The correlations between the QOL parameters and subjective measures of asthma severity, such as symptom scores (range 0.26-0.65) and ß2-agonist use for the relief of symptoms (0.09-0.39), were higher. The correlations of the activity and symptoms domains of the AQLQ with diary-obtained symptom scores were r=0.50 (p[lessthan]0.0001) and r=0.65 (p[lessthan]0.0001), respectively. The correlation between the physical construct of the LWAQ and symptom scores was r=0.42 (p[lessthan]0.001) and that between the physical sumscore of the SF-36 and symptom scores was r=0.50 (p[lessthan]0.001). The correlation between the PGWB and symptom scores was r=0.41 (p[lessthan]0.001). The relation between the FEV1, PEF and PC20 and QOL was very low. The QOL measurements related well to the symptom scores. The AQLQ had a better cross-sectional construct validity than the LWAQ. The cross-sectional construct validity of the SF-36 was surprisingly high for this group of patients and the SF-36 performed better than the PGWB and LWAQ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bousquet J, Knani J, Dhivert H et al. Quality of life in asthma 1. Internal consistency and validity of the SF36 questionnaire.Am J Respirat Crit Care Med 1994; 149: 371-375.

    Google Scholar 

  2. Janson C, Björnsson E, Hetta J, Boman G. Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respirat Crit Care Med 1994; 149: 930-934.

    Google Scholar 

  3. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83.

    Google Scholar 

  4. Hyland ME, Finnis S, Irvine SH. A scale for assessing quality of life in adult asthma sufferers. J Psychosom Res 1991; 35: 99–110.

    Google Scholar 

  5. Rutten-van Mölken MPMH, Custers F, Van Doorslaar EKA et al.Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur J Respirat Dis 1995; 8: 888-898.

    Google Scholar 

  6. Guyatt G, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992; 45: 1341-1345.

    Google Scholar 

  7. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81-87.

    Google Scholar 

  8. Hyland ME, Kenyon CAP, Jacobs PA. Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing salmeterol with placebo in asthmatics. Qual Life Res 1994; 3: 121-126.

    Google Scholar 

  9. van der Molen T, Postma DS, Turner MO et al. Effects of the long-acting ?-agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. Thorax 1997; in press.

  10. Ware JE, Sherbourne CD. The MOS-36-item Short-form Health Status Survey (SF-36): 1. conceptual framework and item selection. Med Care 1992; 30: 473-483.

    Google Scholar 

  11. Wan TTH, Liviratos B. Interpreting a general index of subjective well-being. Milbank Mem Fund 1978; 56: 531-556.

    Google Scholar 

  12. Ware JE, Koskinski M, Keller SD. The health institute, 1994. In: Boston MA, ed. 1994

  13. Ware JE, Kosinski M, Bayliss MS, McHorny CA, Rogers WH, Raczec A. Comparison of methods for the scoring and statistical analysis of SF36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 1995; 33: 264-279.

    Google Scholar 

  14. Kamman R, Flett R. A scale to measure current level of general happiness. Aust J Psychol 1983; 35: 259-265.

    Google Scholar 

  15. Oosterhoff Y, de Jong JW, Koëter GH, Postma DS. The degree of airway responsiveness (AR) to adenosine 5'-monophosphate (AMP) is determined by smoking and allergic state. Am Rev Respirat Dis 1992; 145: A732 (abstract).

    Google Scholar 

  16. Nunnally JC. Psychometric Theory. New York: McGraw-Hill, 1967.

    Google Scholar 

  17. Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ 1992; 305: 1145-1148.

    Google Scholar 

  18. Jenkinson C, Coulter A, Wright L. Shortform 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ 1993; 306: 1437-1440.

    Google Scholar 

  19. van der Zee K, Sanderman R, Heyink J. De psychometrische kwaliteiten van de MOS Short Form Health Survey (SF36) in een Nederlandse populatie. T Soc Gezondheidsz 1993; 71: 183-191.

    Google Scholar 

  20. Cocco G, D'Agostino F, Piotti L, Schiano M, Zanon P, Melillo G. Evaluation of quality of life in asthma. Eur Respirat Rev 1993; 14: 369-372.

    Google Scholar 

  21. Jones PW, Nedocromil Sodium Quality of Live Study Group. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Eur Respirat J 1994; 7: 55-62.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Molen, T., Postma, D.S., Schreurs, A.J.M. et al. Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. Qual Life Res 6, 353–361 (1997). https://doi.org/10.1023/A:1018483310277

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018483310277

Navigation